GANX
Gain Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 17, 2026 12:22:46 PM EST
1.25USD+32.419%(+0.30)2,173,668
Pre-marketNov 17, 2026 9:25:30 AM EST
0.98USD+4.233%(+0.04)
GANX Financials
In Q3 FY 2026 (ended ), Gain Therapeutics, Inc. Common Stock (GANX) reported net income of −$3.16M, operating cash flow of −$3.05M, and assets of $13.23M (filed ).
Loading financial statements…